Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population
- PMID: 18378865
- PMCID: PMC2900836
- DOI: 10.1097/PSY.0b013e31816aa0cc
Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population
Abstract
Objective: To study the prevalence of psychiatric comorbidity based on reference standard diagnostic criteria in patients with human immunodeficiency virus (HIV). Psychiatric illness is common in patients with HIV and has been associated with negative health behaviors and poorer clinical outcomes. Among those persons with psychiatric illness, psychiatric comorbidity (multiple simultaneous diagnoses) is associated with increased psychiatric severity and higher HIV risk behaviors.
Methods: A total of 152 consecutively presenting HIV+ patients at an academic medical center in the southeastern US completed a modified Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4(th) Edition) that assessed mood, anxiety, and substance use disorders in the past year and past month.
Results: Fifty percent and 33% of patients had a past-year and past-month diagnosis, respectively. The most common diagnoses were mood disorders (32% past year/21% past month) followed by anxiety (21%/17%) and substance use disorders (22%/11%). Half of those with past-year disorders and 40% of those with past-month disorders met the criteria for multiple diagnoses. Of those with a mood disorder in the past month, 53% also had an anxiety or substance use disorder; of those with an anxiety disorder, 62% also had a mood or substance use disorder; and of those with a substance use disorder, 63% also had a mood or anxiety disorder. Psychiatric comorbidity was associated with younger age, White non-Hispanic race/ethnicity, and greater HIV symptomatology.
Conclusions: Comorbidity of mood, anxiety, and substance use disorders was the exception rather than the rule in this sample. Potential co-occurring disorders should be considered for HIV+ patients presenting with a psychiatric diagnosis.
Figures
Similar articles
-
Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.J Clin Psychiatry. 2006 Feb;67(2):247-57. doi: 10.4088/jcp.v67n0211. J Clin Psychiatry. 2006. PMID: 16566620
-
Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.Am J Geriatr Psychiatry. 2009 Sep;17(9):769-81. doi: 10.1097/JGP.0b013e3181ad4f5a. Am J Geriatr Psychiatry. 2009. PMID: 19700949
-
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617. Arch Gen Psychiatry. 2005. PMID: 15939839 Free PMC article.
-
Psychiatric and medical comorbidities of bipolar disorder.Psychosom Med. 2005 Jan-Feb;67(1):1-8. doi: 10.1097/01.psy.0000151489.36347.18. Psychosom Med. 2005. PMID: 15673617 Review.
-
A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment.Psychol Assess. 2009 Sep;21(3):256-71. doi: 10.1037/a0016608. Psychol Assess. 2009. PMID: 19719339 Free PMC article. Review.
Cited by
-
Telehealth Interventions for HIV in Low- and Middle-Income Countries.Curr HIV/AIDS Rep. 2022 Dec;19(6):600-609. doi: 10.1007/s11904-022-00630-0. Epub 2022 Sep 26. Curr HIV/AIDS Rep. 2022. PMID: 36156183 Free PMC article. Review.
-
The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.AIDS. 2015 Sep 24;29(15):1975-86. doi: 10.1097/QAD.0000000000000797. AIDS. 2015. PMID: 26134881 Free PMC article. Clinical Trial.
-
The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.AIDS Behav. 2019 Mar;23(3):592-601. doi: 10.1007/s10461-018-2282-3. AIDS Behav. 2019. PMID: 30288684 Free PMC article.
-
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment.Front Cell Neurosci. 2023 Apr 28;17:1130938. doi: 10.3389/fncel.2023.1130938. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37206666 Free PMC article.
-
The Prevalence and Negative Impacts of Substance Use Disorders among People with HIV in the United States: A Real-Time Delphi Survey of Key Stakeholders.AIDS Behav. 2022 Apr;26(4):1183-1196. doi: 10.1007/s10461-021-03473-9. Epub 2021 Sep 29. AIDS Behav. 2022. PMID: 34586532 Free PMC article.
References
-
- Sherbourne CD, Hays RD, Fleishman JA, Vitiello B, Magruder KM, Bing EG, McCaffrey D, Burnam A, Longshore D, Eggan F, Bozzette SA, Shapiro MF. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–54. - PubMed
-
- Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285:1466–74. - PubMed
-
- Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54:295–306. - PubMed
-
- Pence BW, Miller WC, Gaynes BN, Eron JJ., Jr Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44:159–66. - PubMed
-
- Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous